Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The India intravenous solution market is expected to exhibit a CAGR of 5.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Intravenous (IV) solutions are a mix of essential nutrients that replenish fluid loss and treat electrolyte imbalances in IV therapy. They are administered into the venous circulation with the help of a syringe or IV catheter. IV solutions are made of electrolytes, sugar, and medications required by patients suffering from diabetes, cancer and other diseases. They also provide nutrients added in concentrations as per the patient’s medical condition, age, and size.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
India represents one of the largest markets for IV solutions, primarily driven by the increasing population and the rising prevalence of gastrointestinal diseases, neurological disorders, and diabetes. This is due to unhealthy eating habits and sedentary lifestyles. Besides this, various government initiatives related to improving the healthcare infrastructure of the country are also propelling the growth of the market. Additionally, the growing consciousness among individuals regarding their health and the increasing disposable incomes of consumers have enabled them to expand healthcare expenditure, thereby positively impacting the market growth. Furthermore, the availability of these solutions in portable packages has made it easier for patients to use drips in their home’s comfort.
IMARC Group provides an analysis of the key trends in each sub-segment of the India intravenous solution market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on type and nutrients.
Breakup by Type:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
Breakup by Nutrients:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2021 |
| Historical Period | 2016-2021 |
| Forecast Period | 2022-2027 |
| Units | US$ Million |
| Segment Coverage | Type, Nutrients, Region |
| Region Covered | North India, West and Central India, South India, East India |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: 2299 Five User License: 3399 Corporate License: 4499 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the India intravenous solution market to exhibit a CAGR of 5.95% during 2022-2027.
The growing prevalence of several chronic diseases is catalyzing the demand for intravenous
solution, as it provides nutrients added in concentration according to the medical condition, age,
and body weight of the patient, which is currently driving the India intravenous solution market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for intravenous
solutions due to the high rate of hospital admissions for patients suffering from the coronavirus
infection.
Based on the type, the India intravenous solution market has been segmented into partial parenteral
nutrition and total parenteral nutrition. Currently, total parenteral nutrition represents the largest
market share.
Based on the nutrients, the India intravenous solution market can be bifurcated into carbohydrates,
salts and electrolytes, minerals, vitamins, and amino acids. Among these, salts and electrolytes
currently account for the majority of the total market share.
On a regional level, the market has been classified into North India, West and Central India, South
India, and East India, where West and Central India currently dominates the market.
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com